Company name
PolyPeptide Group
Company profile

PolyPeptide Group AG is a specialized Contract Development & Manufacturing Organization (CDMO) for peptide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide serves a fast-growing market, offering products and services from pre-clinical through to commercial stages.

Date, time and room information

Monday, May 4, 15:30 - 15:45, room Sydney

Category
Commercial stage company
Title of the presentation
Speed to Clinics
Speaker information
Name Position Institution
Daniel ÖBERG-ARENDT Senior Sales Manager